Verified research compound
Retatrutide 20mg
Retatrutide is a novel investigational triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This tri-receptor approach represents the latest generation of metabolic research compounds, building on the dual-agonist framework established by earlier peptides. Each vial contains lyophilized retatrutide powder at the selected strength. Reconstitute with bacteriostatic water before use in research applications.
Research Use Only. Intended strictly for in-vitro laboratory research. Not a drug, food, or supplement; not for human or veterinary consumption.
- Purity
- ≥99%
- Molecular Formula
- C221H342N46O68
- CAS Number
- 2381089-83-2
- SKU
- PEP-RETA-20
Storage: Store lyophilized powder at -20°C, protected from light. Stable at room temperature for short periods during handling.
Handling: Handle using standard laboratory safety practices and protective equipment. For in-vitro research use only — not for human or veterinary use.